Skip to content
Certara Drug Interaction Database (DIDB®)
  • Licensing
    • Does my organization have a DIDB® license?
    • Licensing
    • Account policies
  • News
  • Support
  • Contact Us
  • Sign in
June 14, 2022 |  News

Data Curation and Entry in DIDB – May Summary

In May, we added 74 citations in DIDB, including 29 in vitro (with 15 articles published in May 2022) and 45 in vivo articles (with 32 articles published in May 2022).

One recently approved NDA was also added: Ganaxolone (ZTALMY)

You can check the citations that are recently published and entered in DIDB and all the NDAs/BLAs in DIDB.

As always, feel free to contact us if you have any questions or comments.

Post navigation

New features! Drug Characteristics now integrated in queries
Assessing the Effects of Food on Drugs in INDs and NDAs – Clinical Pharmacology Considerations
Follow us on Linked

Recent News

  • Applications of PBPK for Drugs Approved by the US Food and Drug Administration in 2023 and 2024: A Review of Drug Label Clinical Trial Waivers
  • Metabolite Measurement in Index Substrate Drug Interaction Studies: A Review of the Literature and Recent New Drug Application Reviews
  • Risk of Enzyme- and Transporter-Mediated Drug Interactions with Drugs Approved by the US Food and Drug Administration in 2022: A Detailed Analysis of In Vitro and Clinical Data Available in New Drug Application Reviews
  • Pharmacokinetic Drug Interactions with Drugs Approved by the US Food and Drug Administration in 2024: A Review of Clinical Data Available in New Drug Application Reviews
  • Data Curation and Entry in DIDB – September Summary

News Categories

  • Events
  • New features
  • News
  • Posters
  • Publications
  • Blog
  • Contact
  • Privacy
Copyright © 2025 Certara, USA. All Rights Reserved.